City of Industry, CA -- (SBWIRE) -- 06/28/2018 -- This report studies the global Immunotherapy market status and forecast, categorizes the global Immunotherapy market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The amplification of immune response is called as activation immunotherapy and the suppression of the immune response is called suppression immunotherapy.

The global Immunotherapy market is valued at 106900 million US$ in 2017 and will reach 179100 million US$ by the end of 2025, growing at a CAGR of 6.7% during 2018-2025.

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/529147/global-immunotherapy-sales-market

The major players covered in this report

Abbvie

Amgen, Inc.

Biogen

Bristol-Myers Squibb

Celgene

Johnson & Johnson

Merck

Novartis

Pfizer

Roche

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

United States

Europe

China

Japan

Southeast Asia

India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Monoclonal Antibodies

Therapeutic Vaccines

Checkpoint Inhibitors

Non-Specific Immunotherapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Oncology

Inflammation

Central Nervous System

Others

Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/529147/global-immunotherapy-sales-market